Researchers hope to quell a surge of Alzheimer’s cases with new diagnostic tools
08.24.10
Publication: Aaron James By:
New brain-imaging technologies will help the researchers evaluate the drugs’ efficacy. For example, Avid Radiopharmaceuticals of Philadelphia has developed a new dye, AV45, that binds with amyloid proteins, which create the plaques in the brain that are Alzheimer’s hallmarks. The dye makes the plaques visible on a PET scan.
New Data Shows Decline in Medical Imaging Utilization
A new analysis of Medicare data finds that spending on medical imaging continues to decline and that Medicare patients are receiving fewer imaging procedures. Learn More
MITA Now Includes Radiopharmaceutical Industry in Membership
With new membership MITA unites both halves of nuclear medicine. Learn More
CT Lung Cancer Screening Named Top Five Advance in 2011
The American Society of Clinical Oncology (ASCO) named CT-based lung cancer screening amongst 2011’s top five advances in its annual report on progress against cancer. Learn More
- © 2012 National Electrical Manufacturers Association |
- Privacy Policy |
- Terms & Conditions